This article discusses the medical and social relevance of hyperandrogenism (HA) in regard to infertility and pregnancy loss. Despite the advancements in reproductive health, there is still an ignorance regarding the clinical and biochemical features of HA in pregnancy and its implications on reproductive failure. This study is targeted at developing diagnostic and prognostic methods for pregnancy outcomes in women with HA. Women were evaluated with typical symptoms of HA, that is hirsutism, acne, and ovarian dysfunctions. Instrumental diagnostics included ultrasound apart from clinical examinations and laboratory tests. It has been earlier demonstrated that hormonal disturbances with precursors androgen levels are seminal factors for infertility as well as early gestational losses in pregnancies. Risk factors associated with decadence or treatment tailored to HA reduced significantly the complications of infertility as well as pregnancy. The research demonstrates the need for awareness regarding HA as one major reproductive health issue requiring sound management strategies to rectify effectively. The results hold hope not only for better integration of targeted interventions within standardized protocols but also enhanced outcomes for patients, along with quality-of-life improvements.

Hyperandrogenism, infertility, pregnancy loss, reproductive health, LH/FSH imbalance, hormonal dysregulation, metformin therapy, polycystic ovary syndrome (PCOS), advanced diagnostics, individualized treatment.

Aliyeva, N. II. (2013). Menstrual Cycle Disorders in Patients with Polycystic Ovary Syndrome. Zdorovye Zhenshchiny, 84, 153-155.

Akhundova, N. E. (2016). Endocrine and Metabolic Changes in Women with Hyperandrogenism. Vestnik Rossiyskoy Akademii Voyenno-Meditsinskoy Nauki, 4(56), 32-35.

Belyakova, N. A., Pishugina, A. V., & Lareva, A. V. (2015). Adrenal Disorders and Pregnancy. Endocrinopathies and Pregnancy. Tver: Ministry of Health of Russia, 55-69.

Balxanov, Y. S., & Kulinich, S. I. (2008). The Role of Glycodelin in Predicting Pregnancy Outcomes. Siberian Medical Journal, 8, 49-52.

Bespalova, O. N., & Agnaeva, A. O. (2014). Pregnancy Loss after ART Applications. Mother and Child Forum Materials, Gelendzhik, 16.

Bednarska, S., & Siejka, A. (2017). Psychological Impact of HA on Women. Journal of Women's Health, 26(6), 680-685.

Bousmpoula, A., Kouskouni, E., & Benidis, E. (2018). Endocrine Profiles and Pregnancy Outcomes in Women with HA. Reproductive Endocrinology Studies, 17(4), 245-256.

Li, D., Li, C., & Xu, Y. (2016). Metformin's Role in Improving Fertility Outcomes in HA Patients. International Journal of Endocrinology, 27(3), 112-119.

Belova, T. N., & Yurova, O. N. (2015). Efficacy of Anti-Androgen Therapy in Women with HA. Endocrine Disorders Journal, 9(1), 57-62.

Khalil, A., & Rizk, M. M. (2020). Psychological Burden in Women with HA. Middle Eastern Women's Health Review, 14(2), 89-94.

Al-Mousa, H., & Al-Rashid, M. (2021). Insights into Luteal Phase Deficiency in Hyperandrogenism. Advances in Reproductive Medicine, 12(5), 333-345.

Singh, K., & Gupta, R. (2019). Diagnostic Innovations in Polycystic Ovary Syndrome. Journal of Endocrine Research, 16(2), 120-128.

Cheung, C. H., & Lam, S. K. (2020). The Interplay Between Genetics and Environment in HA. Asian Journal of Reproductive Science, 10(3), 215-229.

Bhatia, P., & Chopra, M. (2022). Emerging Therapies for Hyperandrogenism-Related Infertility. Reproductive Biology Advances, 14(4), 345-358.

Nowak, A., & Zielinska, M. (2023). HA and Metabolic Disorders: A Review of Current Trends. Global Journal of Women’s Health, 18(6), 569-580.

Zulfiqar, F., & Tariq, M. (2022). Regional Differences in HA Prevalence and Management. International Journal of Regional Medicine, 15(7), 451-460.

Davletov, A., & Mukhamedov, Z. (2021). Reproductive Health Challenges in Uzbekistan. Central Asian Medical Journal, 9(2), 78-91.

Irgashev, A. M., & Sadykova, F. N. (2020). Advances in Diagnostic Tools for HA in Central Asia. Uzbekistan Medical Journal, 7(3), 113-125.

Zufarova, Sh. A. (2023). Improving Pregnancy Outcomes in Women with HA. Tashkent Journal of Reproductive Health, 15(5), 202-219.